ESTA — Establishment Labs Holdings Share News
0.000.00%
Last trade - 00:00- $1.83bn
- $2.02bn
- $211.08m
Brief: Establishment Labs Says Center For Devices & Radiological Health Of FDA Finished Review Of Co's Premarket Approval Application For Motiva Implants
Brief: Establishment Labs Announces Amended Credit Facility With Oaktree
Brief: Establishment Labs Holdings - Offering, Sale From Time To Time Of Up To 2 Million Common Shares, No Par Value Per Share By Selling Shareholders
U.S. STOCKS ON THE MOVE-Instacart, Nvidia, Novavax
U.S. STOCKS ON THE MOVE-Emeren Group, Tesla, Parker-Hannifin
Brief: Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
U.S. STOCKS ON THE MOVE-Eli Lilly, Innovid, New York Times
Brief: Establishment Labs Announces FDA Clearance Of Motiva Flora Smoothsilk Tissue Expander
Brief: Establishment Labs Reports Record First Quarter 2023 Financial Results
Brief: Establishment Labs Holdings Prices Public Offering Of 1.1 Million Common Shares At A Price Of $71.50 Per Share
Brief: Establishment Labs Announces Proposed Public Offering Of Common Shares
Brief: Establishment Labs Announces Preliminary Unaudited Results For First Quarter 2023
Brief: Establishment Labs Holdings Inc Says Announced Launch Of Mia Femtech ("Mia") In Japan
Brief: Establishment Labs Announces First Mia Femtech™ Partners In Europe And Second Partner Chain In Japan
Brief: Establishment Labs Holdings Inc - 2023 Rev guidance Of $200 mln To $210 mln, An Increase Of 24% To 30% Over 2022
Brief: Establishment Labs Holdings Inc Expects To Achieve $500 Mln In Annual Revenue In Fiscal Year 2026
Brief: Establishment Labs Announces Preliminary Unaudited Revenue For Fourth Quarter And Fiscal Year 2022
Brief: Establishment Labs Holdings Inc Enters Into An Agreement With Seishin Plastic And Aesthetic Surgery Clinic In Japan For Mia Femtech
Brief: Establishment Labs Announces Japanese Regulatory Approval And Reimbursement For Motiva Implants